Neurocrine Biosciences
NBIX
#1326
Rank
โ‚ฌ14.85 B
Marketcap
147,74ย โ‚ฌ
Share price
2.64%
Change (1 day)
37.85%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2026 (TTM): โ‚ฌ0.68 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are โ‚ฌ3.10 Billion. In 2025 the company made an earning of โ‚ฌ0.55 Billion, an increase over its 2024 earnings that were of โ‚ฌ0.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.68 B22.24%
2025 โ‚ฌ0.55 B3.9%
2024 โ‚ฌ0.53 B96.41%
2023 โ‚ฌ0.27 B41.13%
2022 โ‚ฌ0.19 B73.74%
2021 โ‚ฌ0.11 B-8.82%
2020 โ‚ฌ0.12 B77.78%
2019 โ‚ฌ68.79 M49.83%
2018 โ‚ฌ45.91 M-142.57%
2017 -โ‚ฌ0.11 Billion-14.73%
2016 -โ‚ฌ0.13 Billion53.15%
2015 -โ‚ฌ82.59 Million46.25%
2014 -โ‚ฌ56.47 Million29.66%
2013 -โ‚ฌ43.56 Million-3530.8%
2012 โ‚ฌ1.26 M-95.73%
2011 โ‚ฌ29.73 M
2009 -โ‚ฌ41.81 Million-45.38%
2008 -โ‚ฌ76.54 Million-58.87%
2007 -โ‚ฌ0.19 Billion87.3%
2006 -โ‚ฌ99.35 Million351.97%
2005 -โ‚ฌ21.99 Million-52.09%
2004 -โ‚ฌ45.89 Million-10.98%
2003 -โ‚ฌ51.54 Million
2001 -โ‚ฌ38.48 Million
1999 -โ‚ฌ17.35 Million108.32%
1998 -โ‚ฌ8.33 Million
1996 โ‚ฌ2.54 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ9.28 B 1,225.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ5.78 B 725.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.28 B 3,796.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ73.55 M-89.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚ฌ36.62 Million-105.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ83.97 M-88.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ4.21 Million-100.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ1.48 B 112.21%๐Ÿ‡ฌ๐Ÿ‡ง UK